There is a phrase that every FemTech founder should keep somewhere visible: “The road to harm is paved with good intentions.”
Because in this industry, harm rarely comes from carelessness but from care that was never checked.
Over the last two weeks, we have been building the foundation of a clinically credible FemTech product. We started with data governance, and then moved to patient safety.
But both of those pillars live largely behind the scenes. Your users will never see your data governance policy or your clinical risk register. What they will see every single time they open your app is this week’s pillar: patient and user experience.
And this is where good intentions become most dangerous.
The Gap
User experience in consumer tech is built around one goal: make the person feel good enough to return. That logic works perfectly for a music app or a food delivery platform. It becomes a clinical liability when the product is making health-related claims.
FemTech sits in an uncomfortable middle ground. It is expected to be warm, accessible, and emotionally intelligent, because women have spent decades being failed by cold, one-size-fits-all healthcare. That warmth is one of the industry’s genuine strengths.
But warmth without accuracy is not care. It is performance. And there are two places in particular where that performance creates real risk for real users.
Friction Point One: Engagement Over Evidence
The first problem lies in your copy, specifically, in the gap between what your data shows and what your notifications say.
Health apps are under constant pressure to drive retention, so products default to positive reinforcement: motivational language, celebratory framing, and insights that focus on what is going well rather than what the data is actually saying.
Founders tell themselves they are reducing health anxiety and making medicine feel human. And in many cases, that is true.
But when a user’s tracked data shows a pattern that warrants clinical attention and your app responds by telling her she is thriving, she has no reason to dig deeper or see a doctor. That is a clinical accuracy problem, and it is almost impossible to catch without a process that specifically looks for it, because from a retention standpoint, those notifications are working perfectly.
Friction Point Two: Complaints That Never Reach a Clinician
The second problem lies in your inbox.
Every FemTech product with a meaningful user base is already receiving signals that something may be clinically off: users reporting inaccurate predictions, feeling more confused after using the app, or leaving reviews that say “it told me I was fine and I wasn’t.” These messages get logged, tagged, and passed to your product manager. What they almost never do is reach someone with the clinical training that’ll not ask “how do we fix this feature?“ but “is this a safety signal?”
Those are fundamentally different questions, and the two friction points are connected.
When your notifications consistently tell users everything is fine, the ones who know something is not fine will contact support. Your inbox is already functioning as a clinical feedback channel. You just have not set it up that way.
The Credibility Fix
The solution to both problems is the same: bring clinical judgment into parts of your product where it currently does not exist.
For your copy, pull your five most frequently triggered notifications and ask, “Is there a version of my user’s data where this message is clinically inaccurate or misleading?” If yes, flag it before it goes out again.
Going forward, no notification or in-app message should go live without one clinical check: “Is this accurate across every version of user data that could trigger it, not just the best case?”
For your inbox, pull the last 30 complaints or low ratings and send them to your medical advisor with one ask: do any of these suggest our product gave a user a misleading picture of her health? Then make this a monthly habit: a clinician reviewing a sample of tickets specifically for safety patterns, not product fixes.
Neither requires a large team. Both require one decision: that clinical accuracy is a product responsibility, not a legal afterthought.
Your users are already telling you what they need. You just need to make sure the right person in your organization is listening.
Next week, we tackle pillar four — Communication and Clinical Audit. We will get into the question that separates credible health products from clever ones: how do you actually prove your product is improving outcomes?
See you then.
Better Woman Health is published weekly.
Subscribe at betterwomanhealth.com to get it directly in your inbox.
Clinical Credibility Toolkit
The Clinical Credibility Toolkit is a free resource designed for FemTech founders building digital tools for women’s health.
It includes the Clinical Credibility Scorecard, a 28-question assessment that helps you identify gaps in your clinical foundation, evidence strategy, safety architecture, and investor readiness, and the Red Flag Detection Checklist, a 25-question assessment that tells you whether your symptom-tracking app can actually detect and act on medical red flags, not just log them.
If you are preparing to pitch, pursuing healthcare partnerships, or simply want to know where your product stands clinically, start here.
Access the toolkit → app.ayomide.me
Thanks for reading. See you soon!
Dr. Ayomide O.
FemTech Credibility Advisor
Find me on LinkedIn or Book a 1:1 Call
